Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled date : 2021 - 07 - 27    source : Www.biospace.com    save search

Nanox to Announce Second Quarter 2021 Financial and Operating Results on Tuesday, August 10, 2021Management to host conference call and webcast at 8:30 AM ET on that day
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
NNOX | News | $9.12 -2.04% 300K twitter stocktwits trandingview |
Health Technology
| | O: -1.37% H: 2.64% C: 1.72%

results conference
Clinical Utility of ALK Fusion Detection by Liquid Biopsy
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
A | $137.51 -1.21% 720K twitter stocktwits trandingview |
Health Technology
| | O: -0.64% H: 0.48% C: 0.44%


Entasis Therapeutics and Zai Lab Complete Patient Enrollment in the ATTACK Phase 3 Registrational Clinical Trial of Sulbactam-Durlobactam
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
ZLAB | $15.61 3.24% 250K twitter stocktwits trandingview |
Health Technology
| | O: -5.31% H: 0.35% C: -6.83%
ETTX | $2.19 -0.46% 0.46% twitter stocktwits trandingview |
Health Technology
| | O: 0.42% H: 0.0% C: -3.54%

phase 3 trial enroll
Capricor Therapeutics Announces the Appointment of Karimah Es Sabar to its Board of Directors
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
SNY | News | $46.615 -2.25% 730K twitter stocktwits trandingview |
Health Technology
| | O: -0.54% H: 0.65% C: 0.49%
CAPR | $5.12 6.22% 670K twitter stocktwits trandingview |
Health Technology
| | O: 0.42% H: 0.05% C: -3.33%


SpringWorks Therapeutics Appoints Dr. James Cassidy as Chief Medical Officer
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
SWTX | $43.82 -0.41% 180K twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 1.84% C: 0.21%

therapeutics
AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
ACIU | $2.37 -0.42% 82K twitter stocktwits trandingview |
Health Technology
| | O: 1.83% H: 2.76% C: -1.24%

disease neurodegenerative immunotherapy therapy alpha-synuclein
Lantern Pharma Reacquires Rights to Phase 2 Clinical Trial in Metastatic Prostate Cancer and Global Development & Commercialization of Irofulven (LP-100) from Allarity Therapeutics A/S
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
LTRN | News | $5.75 -0.35% 52K twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 1.32% C: -2.48%

phase 2 commercialization prostate cancer cancer trial
Vyant Bio to Present at A.G.P.’s Virtual MedTech Summer Conference
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
VYNT | $0.194 -8.51% 19K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 3.72% H: 0.0% C: -7.17%

conference
Health Catalyst to Announce Second Quarter 2021 Operating Results and Host Conference Call on Thursday, August 5, 2021
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
HCAT | $5.81 3.75% 210K twitter stocktwits trandingview |
Technology Services
| | O: -0.66% H: 1.85% C: 0.97%

results conference
Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -25.68% H: 4.24% C: -7.88%

phase 2 cancer breast cancer trial
Kronos Bio Announces FDA Clearance of Investigational New Drug Application for Lanraplenib (LANRA) for Treatment of Patients with Acute Myeloid Leukemia (AML)
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
KRON | $0.9899 4.2% 550K twitter stocktwits trandingview |
Health Technology
| | O: 1.29% H: 0.0% C: -2.49%

new drug fda clearance treatment fda myeloid leukemia drug leukemia clearance acute myeloid leukemia aml
The New SmartStage™ XY Linear Positioner from Dover Motion
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
FTV | $77.13 -4.42% 4M twitter stocktwits trandingview |
Electronic Technology
| | O: -0.67% H: 0.74% C: 0.38%


Allogene Therapeutics to Report Second Quarter Financial Results on August 4, 2021Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
ALLO | $3.095 -8.16% 910K twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 2.04% C: 0.28%

financial results results conference
Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
ABBV | News | $168.21 -0.78% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.43% C: 0.14%
AMGN | News | $274.15 0.22% 900K twitter stocktwits trandingview |
Health Technology
| | O: -0.39% H: 0.61% C: 0.23%

milestone
Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
SRDX | $26.115 -2.99% 10K twitter stocktwits trandingview |
Health Technology
| | O: -0.02% H: 0.0% C: -1.03%

conference
NexImmune to Announce Second Quarter 2021 Financial Results and Provide Corporate Update on August 9, 2021
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
NEXI | $3.43 5.6K twitter stocktwits trandingview |
| | O: -1.57% H: 0.0% C: -7.82%

financial results results
I-Mab Announces Preliminary Proposal for Potential Dual Listing on the STAR Market of the Shanghai Stock Exchange
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
IMAB | $1.805 0.28% 31K twitter stocktwits trandingview |
Health Technology
| | O: -3.42% H: 1.32% C: -0.13%

potential
BioFlyte Forms Scientific Advisory Board of Prominent Government and Life Science Experts
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
PKI | $115.24 0.0% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.66% H: 0.73% C: -1.78%
NVIV | $0.3207 -25.16% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 2.67% C: 0.02%

life science
Immunomic Therapeutics Expands Board of Directors with Appointments of Two New Members
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
MS | News 0 d | $93.38 -0.41% 1.8M twitter stocktwits trandingview |
Finance
| | O: -0.68% H: 1.22% C: 0.63%


Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
BVS 4 | $4.2 -2.55% 53K twitter stocktwits trandingview |
| | O: 0.48% H: 1.15% C: 0.0%
MS | News 0 d | $93.38 -0.41% 1.8M twitter stocktwits trandingview |
Finance
| | O: -0.68% H: 1.22% C: 0.63%

growth conference
Gainers vs Losers
56% 44%

Top 10 Gainers
CZOO | $10.52 110.82% 10M twitter stocktwits trandingview |

CSSE 4 | $0.3181 108.86% 170M twitter stocktwits trandingview |
Consumer Services

BOF | $1.88 60.68% 98M twitter stocktwits trandingview |

AMST | $3.1 55.0% 66M twitter stocktwits trandingview |
Technology Services

LICN | $0.8592 53.43% 13M twitter stocktwits trandingview |

WIMI | $1.03 41.99% 15M twitter stocktwits trandingview |
Technology Services

MULN | News | $3.675 34.62% 11M twitter stocktwits trandingview |
Information

RILY | $28.605 31.7% 9.9M twitter stocktwits trandingview |
Finance

RBBN 4 | $3.305 28.6% 1.9M twitter stocktwits trandingview |
Electronic Technology

RCAT | $1.53 27.5% 2.9M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.